385P Efficacy and safety of pyrotinib in untreated, advanced non-small cell lung cancer with HER2 mutations: A parallel, multi-center, multi-cohort patient-centric study (CTONG1702 and 1705)
Annals of Oncology(2022)
关键词
her2 mutations,lung cancer,pyrotinib,non-small,multi-center,multi-cohort,patient-centric
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要